SOLAS BIOVENTURES MANAGEMENT, LLC
SOLAS BIOVENTURES MANAGEMENT, LLC is a Pre-seed, Seed, Series A and Series B fund in Global writing $250K–$5M checks into Healthcare, biopharmaceuticals, medical-devices and life-sciences.
- Stages
- Pre-seed, Seed, Series A, Series B
- Sectors
- Healthcare, biopharmaceuticals, medical-devices, life-sciences
- Check size
- $250K–$5M
- Invests in
- Global
- Actively investing
- Yes
- Founded
- 2015
- Assets under management
- $100 million
- Website
- solasbio.com
Thesis
Solas BioVentures, founded in 2015, is a venture capital firm with a fund size of $100 million, specializing in early-stage life sciences companies globally. The firm focuses on biopharmaceuticals, medical devices, and digital health, targeting pre-seed, seed, Series A, and Series B rounds. Solas BioVentures emphasizes a founder-centric approach, providing tailored support and leveraging expertise in medical, biotech, operational, and financial domains. They prioritize products or services with significant patient outcome impacts that offer asymmetric return profiles favoring investors. Typical check sizes range from $250,000 to $5 million.
Common questions
Does SOLAS BIOVENTURES MANAGEMENT, LLC invest at the Pre-seed stage?
Yes. SOLAS BIOVENTURES MANAGEMENT, LLC lists Pre-seed, Seed, Series A and Series B among the stages it invests in.
What check size does SOLAS BIOVENTURES MANAGEMENT, LLC write?
SOLAS BIOVENTURES MANAGEMENT, LLC writes $250K–$5M checks.
Where does SOLAS BIOVENTURES MANAGEMENT, LLC invest?
SOLAS BIOVENTURES MANAGEMENT, LLC invests in Global.